These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23464456)

  • 1. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
    Guo ZJ; Feng CL
    Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
    Zhang H; Wen X; Lu X; Zhang H
    Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis.
    Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H
    Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
    Ding R; Lin S; Chen D
    Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
    Yang S; Zhao J; Li L
    Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
    Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
    Yadav U; Kumar P; Rai V
    Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.
    Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH
    PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Gong M; Yi Q; Wang W
    Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
    Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
    Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between NQO1 C609T polymorphism and colorectal cancer risk.
    Wang Y; Zhang G; Luo Y
    Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NAD(P)H: quinine oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with gastric cancer risk: evidence from a case-control study and a meta-analysis.
    Hu WG; Hu JJ; Cai W; Zheng MH; Zang L; Wang ZT; Zhu ZG
    Asian Pac J Cancer Prev; 2014; 15(5):2363-7. PubMed ID: 24716985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.
    Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z
    Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.
    Li C; Zhou Y
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):873-81. PubMed ID: 24488035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.
    Yu H; Liu H; Wang LE; Wei Q
    PLoS One; 2012; 7(1):e30566. PubMed ID: 22272361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
    Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
    Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
    Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
    Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.
    Lajin B; Alachkar A
    Br J Cancer; 2013 Sep; 109(5):1325-37. PubMed ID: 23860519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk.
    Wang Z; Hu J; Zhong J
    DNA Cell Biol; 2012 Apr; 31(4):560-7. PubMed ID: 22017531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
    Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
    J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.